ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

OMB reviewing Administration’s Reauthorization Bill; NCI Special Authority Probably Will Remain

April 15, 1988

New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million

June 25, 1982

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

June 4, 1982